Fig. 7: Combination treatments affect proliferation and adhesion in vivo.

Immunohistochemical stainings of (A) Ki67, (B) ß-Catenin, and (C) E-cadherin of CAM-xenografts derived from control, Combi and SARB-treated HCT116 tumor cells. Upper panel shows ×20 magnifications; Scale bar—50 µm. Lower panel shows ×40 magnifications; Scale bar—20 µm